» Articles » PMID: 30772480

Therapeutics Strategies Against Cancer Stem Cell in Breast Cancer

Overview
Publisher Elsevier
Date 2019 Feb 18
PMID 30772480
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is known as a most prevalent cancer and second deadly cancer, among women worldwide. Due to the high incidence rate of breast cancer and limitations of conventional therapy it seemed essential to look for new targets in cancer cells and directly target them such as target therapy on breast cancer stem cells. In this review we indicate some of therapeutic uses of cancer stem cells in breast cancer. Some strategies are targeting surface specific markers and activated signaling pathways in their microenvironment such as Notch, Hedgehog, Wnt/b-catenin, PI3K/Akt, NF-kB, BMP and TGF-β and their maintenance and drug resistance, using various miRNAs, enhancement of CSCs apoptosis, differentiation therapy, blocking epithelial to mesenchymal transition and using different natural compounds. Recent studies have shown that cancer stem cells play major roles in target therapy on breast cancer. The new manipulation approaches of cancer stem cells can be used as target therapy of breast cancer that were highlighted for immunotherapy of cancer.

Citing Articles

Synthesis and biological evaluation of thiourea-tethered benzodiazepinones as anti-proliferative agents targeting JAK-3 kinase.

Dhawan B, Alam M, Hamid H, Yadav A, Akhter G, Dar M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40029384 DOI: 10.1007/s00210-025-03853-1.


Crosstalk of methylation and tamoxifen in breast cancer (Review).

Shen J, He Y, Li S, Chen H Mol Med Rep. 2024; 30(4).

PMID: 39129315 PMC: 11338244. DOI: 10.3892/mmr.2024.13304.


Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF-κB in Human Breast Cancer Cells.

Ravish A, Narasimhachar B, Xi Z, Vishwanath D, Mohan A, Gaonkar S Biomedicines. 2023; 11(10).

PMID: 37893090 PMC: 10604619. DOI: 10.3390/biomedicines11102716.


Update on immune-based therapy strategies targeting cancer stem cells.

Izadpanah A, Mohammadkhani N, Masoudnia M, Ghasemzad M, Saeedian A, Mehdizadeh H Cancer Med. 2023; 12(18):18960-18980.

PMID: 37698048 PMC: 10557910. DOI: 10.1002/cam4.6520.


A divide and conquer approach to maximise deep learning mammography classification accuracies.

Jaamour A, Myles C, Patel A, Chen S, McMillan L, Harris-Birtill D PLoS One. 2023; 18(5):e0280841.

PMID: 37235566 PMC: 10218746. DOI: 10.1371/journal.pone.0280841.